구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-5 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Inhaled corticosteroid (ICS, Inhaled corticosteroid, Inhaled corticosteroid (ICS) therapy) Sanofi·Asthma 243 trials |
|---|---|
Overview Program | Inhaled corticosteroid (ICS) therapy |
Overview Company | Sanofi |
Overview Modality | ANTIBODY |
Overview Target | Asthma |
Overview Indication | Asthma |
Overview Phase | PHASE_3 |
Overview Status | ACTIVE |
Overview Content status | Limited Data |
Overview Data Confidence | Data Confidence · Low |
Overview Development Signal | Development Signal · Emerging |
Overview Approval status | Investigational |
MoA Mechanism | , comparative clinical efficacy, prescribing patterns, safety outcomes, and future directions for individualized therapy |
MoA Biomarker | Biomarkers |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Comparing the Safety Profiles of Vaginally Administered Misoprostol and Dinoprostone: A Retrospective Pharmacovigilance Study.. Misoprostol and dinoprostone are the most commonly used agents for cervical ripening during labour induction. However, comparative safety data remain limited, particularly regarding rare adverse events and off-label use. Data were obtained from the FDA Adverse Event Repor… |
Clinical Safety signal | Comparing the Safety Profiles of Vaginally Administered Misoprostol and Dinoprostone: A Retrospective Pharmacovigilance Study.. Misoprostol and dinoprostone are the most commonly used agents for cervical ripening during labour induction. However, comparative safety data remain limited, particularly regarding rare adverse events and off-label use. Data were obtained from the FDA Adverse Event Repor… |
Clinical Result source | ClinicalTrials.gov NCT00529529 |
Clinical Program phase | PHASE_3 |
Clinical Trial activity | No active/completed counts |
Clinical Trial ref | NCT00529529 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-5 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Inhaled corticosteroid (ICS, Inhaled corticosteroid, Inhaled corticosteroid (ICS) therapy) Sanofi·Asthma 243 trials |
|---|---|
Overview Program | Inhaled corticosteroid (ICS) therapy |
Overview Company | Sanofi |
Overview Modality | ANTIBODY |
Overview Target | Asthma |
Overview Indication | Asthma |
Overview Phase | PHASE_3 |
Overview Status | ACTIVE |
Overview Content status | Limited Data |
Overview Data Confidence | Data Confidence · Low |
Overview Development Signal | Development Signal · Emerging |
Overview Approval status | Investigational |
MoA Mechanism | , comparative clinical efficacy, prescribing patterns, safety outcomes, and future directions for individualized therapy |
MoA Biomarker | Biomarkers |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Comparing the Safety Profiles of Vaginally Administered Misoprostol and Dinoprostone: A Retrospective Pharmacovigilance Study.. Misoprostol and dinoprostone are the most commonly used agents for cervical ripening during labour induction. However, comparative safety data remain limited, particularly regarding rare adverse events and off-label use. Data were obtained from the FDA Adverse Event Repor… |
Clinical Safety signal | Comparing the Safety Profiles of Vaginally Administered Misoprostol and Dinoprostone: A Retrospective Pharmacovigilance Study.. Misoprostol and dinoprostone are the most commonly used agents for cervical ripening during labour induction. However, comparative safety data remain limited, particularly regarding rare adverse events and off-label use. Data were obtained from the FDA Adverse Event Repor… |
Clinical Result source | ClinicalTrials.gov NCT00529529 |
Clinical Program phase | PHASE_3 |
Clinical Trial activity | No active/completed counts |
Clinical Trial ref | NCT00529529 |
추천 비교
추천 비교